Peptide-mediated cell delivery: application in protein target validation.
about
Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptidesTreatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptideCell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cellsExcision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinaseProtein transduction therapy into cochleae via the round window niche in guinea pigs.Internalization of novel non-viral vector TAT-streptavidin into human cells.Amphipathic peptides and drug delivery.Delivery of TAT/PTD-fused proteins/peptides to islets via pancreatic duct.On the mechanism of eukaryotic cell penetration by α- and β-oligoarginines--targeting infected erythrocytes.Nona-arginine facilitates delivery of quantum dots into cells via multiple pathways.Cell penetrating peptide inhibitors of nuclear factor-kappa B.Characterisation of cell-penetrating peptide-mediated peptide deliveryChallenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment.Direct protein delivery to mammalian cells using cell-permeable Cys2-His2 zinc-finger domains.Construction of the recombinant vaccine based on T-cell epitope encoding Der p1 and evaluation on its specific immunotherapy efficacy.Protein delivery using Cys2-His2 zinc-finger domains.Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo.Influence of protein transduction domains on intracellular delivery of macromolecules.The taming of the cell penetrating domain of the HIV Tat: myths and realities.Efficient cytosolic delivery of molecular beacon conjugates and flow cytometric analysis of target RNA.A cell-penetrating peptide suppresses the hypoxia inducible factor-1 function by binding to the helix-loop-helix domain of the aryl hydrocarbon receptor nuclear translocatorMinimal determinants for binding activated G alpha from the structure of a G alpha(i1)-peptide dimerLung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity.Functional cell permeable motifs within medically relevant proteins.Cre Fused with RVG Peptide Mediates Targeted Genome Editing in Mouse Brain Cells In VivoExploring transduction mechanisms of protein transduction domains (PTDs) in living cells utilizing single-quantum dot tracking (SQT) technologyAT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal Spray.Dendritic Guanidines as Efficient Analogues of Cell Penetrating PeptidesThe core-inversible micelles for hydrophilic drug delivery.Identification of a pivotal endocytosis motif in c-Met and selective modulation of HGF-dependent aggressiveness of cancer using the 16-mer endocytic peptide.The agony of choice: how to find a suitable CPP for cargo delivery."Soft" calcium crosslinks enable highly efficient gene transfection using TAT peptideNoncovalent protein transduction in plant cells by macropinocytosis.Transfection and expression of plasmid DNA in plant cells by an arginine-rich intracellular delivery peptide without protoplast preparation.Suppression of gene expression by a cell-permeable Tet repressor.The C terminus of the nucleoprotein of influenza A virus delivers antigens transduced by Tat to the trans-golgi network and promotes an efficient presentation through HLA class I.Hydrophobicity drives the cellular uptake of short cationic peptide ligands.Factors controlling the efficiency of Tat-mediated plasmid DNA transfer.Cellular internalization of green fluorescent protein fused with herpes simplex virus protein VP22 via a lipid raft-mediated endocytic pathway independent of caveolae and Rho family GTPases but dependent on dynamin and Arf6.Elucidating the function of penetratin and a static magnetic field in cellular uptake of magnetic nanoparticles.
P2860
Q24793327-DCA3BB88-6C27-4A64-B95A-AE96C7D41137Q24796110-7EF7439F-A2BF-46B5-986B-F19F5E97FECCQ24814987-5080E3FA-5665-45D7-B030-083377EE7B1EQ28480614-5790916C-4095-4CB3-84DE-98C2D8BA7FF2Q30375640-659DCB8D-B96B-4E7E-B26D-5FFBF6A20F85Q30478844-81DABBDE-F49D-42C7-BF20-1D0D5865A71DQ30917891-E0358E9F-E0A8-4271-8DD2-10319ED2BBB5Q33220618-CC368267-9B2E-462C-9749-C6D9F5D82F6FQ33801301-B544FDCB-8501-4730-9530-5FEBF702416CQ34247875-2F0BFA44-79FF-4EFB-8576-A7B13FEA6909Q34289086-2DC6393E-254B-4D75-9663-C9B89A3C7E9DQ35049077-303E215E-1884-40F5-8BE5-4AC465CB6879Q35207622-38F7D000-BAB9-4FDB-B247-8257F44B9F91Q35461043-97E214C6-5AC3-4F28-836F-ABFE4ED5CEE2Q35791686-2A3BCDD1-8377-4A76-BC42-A5C1F655F593Q35900519-CC29AC7C-B2F5-444F-868A-FEBF1E8A8FB5Q36316659-688AD257-1A24-4C02-BC9D-1089E28191C1Q36640321-5A8F87DB-0CBD-4699-8920-33920A7BBED8Q36695464-28084F99-5D3B-4D07-8ADA-2AED96BBD93DQ36777816-40E71798-EC5E-4C14-A9B1-F7DBA97B772BQ36865718-B1D27D9A-78A8-43B4-8D56-4952AFD63B1FQ37002824-B923E025-1E2F-48C6-99C0-BFACEC9C211FQ37052581-6EE53137-7D3C-4122-BDEE-32E918937F78Q37131611-FE25561A-DB60-4A22-8E99-D116DF88ADC2Q37534848-FA3C7F94-0142-43A5-909D-C1E5527391BAQ37988482-33F7D63A-BA1F-4A45-9712-90499149791FQ38814333-4FA7045C-7668-473F-8702-CA8B1EBFBBFBQ38974213-01E8D8FF-FB0F-4006-8E73-618D27ECADA7Q39138378-2F53669B-70DC-4410-9BA6-26950150717EQ39360670-1E298669-368A-46F2-A314-C38C59183D75Q39374022-7DE2ED36-4437-4AB8-B7EB-FB6071362B3DQ39793490-BD406F28-666C-4F32-9E5F-B1D96967B384Q40163787-EF5D1E8D-5503-40EA-B3F9-265B59E1EC71Q40223505-86AD6CE1-A01D-4429-AEA6-5C872D17B1E1Q40315427-7D5005AB-F462-4A5E-9B9D-28F8B33E1005Q40347955-277DD568-5A84-4ED2-80CE-9771721222DBQ41616191-D590D397-CF7A-4402-903B-D89232778794Q41913898-57E4E620-318F-411F-A44B-BCE0AFC3B1C7Q41942565-05F63A42-468A-4084-92E1-06971C9ECFF1Q41998121-A40F0D11-BD66-4773-AD1B-A4250CBDEA0F
P2860
Peptide-mediated cell delivery: application in protein target validation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Peptide-mediated cell delivery: application in protein target validation.
@ast
Peptide-mediated cell delivery: application in protein target validation.
@en
Peptide-mediated cell delivery: application in protein target validation.
@nl
type
label
Peptide-mediated cell delivery: application in protein target validation.
@ast
Peptide-mediated cell delivery: application in protein target validation.
@en
Peptide-mediated cell delivery: application in protein target validation.
@nl
prefLabel
Peptide-mediated cell delivery: application in protein target validation.
@ast
Peptide-mediated cell delivery: application in protein target validation.
@en
Peptide-mediated cell delivery: application in protein target validation.
@nl
P1476
Peptide-mediated cell delivery: application in protein target validation.
@en
P2093
Mark A Lindsay
P304
P356
10.1016/S1471-4892(02)00199-6
P577
2002-10-01T00:00:00Z